Risks of tisagenlecleucel therapy for relapsed or refractory b-cell lymphomas
Peer-Reviewed Publication
Updates every hour. Last Updated: 4-May-2025 17:09 ET (4-May-2025 21:09 GMT/UTC)
Chimeric antigen receptor T-cell or CAR T therapy shows promise for patients with refractory or relapsing B-cell lymphomas. Now, however, a new study from Juntendo University highlights a previously unrecognized and severe adverse effect of this therapy in certain patients: laryngeal edema. Researchers identified risk factors for the condition and emphasized that early steroid treatment can manage the condition effectively without impacting the efficacy of CAR T-cell therapy, improving the safety and outcomes of treatment.
Researchers in Japan have demonstrated the high accuracy of their newly developed typhoon observation device that can be dropped from an aircraft into the eye of a typhoon. This kind of device, called a dropsonde, measures storm’s atmospheric conditions as it falls from altitude to the ocean surface. The new dropsonde is lightweight and is made mainly of a biodegradable material. It can descend without a parachute unlike conventional dropsondes.
A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has been developed, as reported by researchers from Science Tokyo. Their innovative design leverages BRET—bioluminescence resonance energy transfer—and exhibits great potential for point-of-care testing, therapeutic drug monitoring, and environmental applications using paper-based devices.
Prostate cancer, especially in advanced stages such as castration-resistant prostate cancer, is challenging to treat. Traditional therapies targeting androgen receptor (AR) signaling have limited efficacy. In a recent study, Japanese researchers investigated the potential of azolato-bridged dinuclear platinum(II) complexes, particularly 5-H-Y, as promising alternatives. Their findings highlight the complex’s ability to inhibit AR signaling and induce cell death in prostate cancer cells, providing a new avenue for prostate cancer treatment.